Clincosm LogoSign in Get a demo

Colorectal Cancer

Showing NaN - NaN of 138
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Colorectal Cancer Screening in Cystic Fibrosis

Recruiting
  • Cystic Fibrosis
  • +2 more
  • Stool tests
  • Los Angeles, California
  • +24 more
Jan 26, 2023

Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in France, United Kingdom, United States (NUC-3373 +

Recruiting
  • Colorectal Cancer
  • +4 more
  • NUC-3373 + leucovorin
  • +8 more
  • Boston, Massachusetts
  • +9 more
Jan 23, 2023

Colorectal Cancer, Coffee, Gastrointestinal Microbiome Trial in Boston (Nestlé NESCAFÉ® TASTER'S CHOICE® House Blend capsule.,

Not yet recruiting
  • Colorectal Cancer
  • +6 more
  • Nestlé NESCAFÉ® TASTER'S CHOICE® House Blend capsule.
  • Placebo
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 19, 2023

Melanoma, Colorectal Cancer, Non-Small-Cell Lung Cancer Trial in Springdale, Nashville (PF-07799933, binimetinib, cetuximab)

Recruiting
  • Melanoma
  • +4 more
  • Fayetteville, Arkansas
  • +23 more
Jan 19, 2023

Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in Worldwide (AMG820 and pembrolizumab)

Completed
Has Results
  • Pancreatic Cancer
  • +2 more
  • AMG820 and pembrolizumab
  • Atlanta, Georgia
  • +14 more
Jan 18, 2023

Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

Recruiting
  • Minimal Residual Disease
  • +11 more
  • ELI-002 2P
  • Duarte, California
  • +10 more
Jan 18, 2023

KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small Cell Lung, NSCLC Trial (JDQ443, trametinib, Ribociclib)

Recruiting
  • KRAS G12C Mutant Solid Tumors
  • +10 more
  • Boston, Massachusetts
  • +5 more
Jan 11, 2023

NSCLC, Colorectal Cancer, Advanced Solid Tumors Trial in Worldwide (GDC-6036, Atezolizumab, Cetuximab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Duarte, California
  • +68 more
Jan 10, 2023

An Optimized Multi-Target Stool DNA Test, for Colorectal Cancer

Active, not recruiting
  • Colorectal Cancer
  • mt-sDNA 2.0 screening test
  • +2 more
  • Birmingham, Alabama
  • +191 more
Jan 9, 2023

2019-01: "Clinical Validation ofOptimized Multi-Target Stool DNA

Active, not recruiting
  • Colorectal Cancer
  • Blood Sample Collection
  • Birmingham, Alabama
  • +189 more
Jan 9, 2023

Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

Active, not recruiting
  • Melanoma
  • +7 more
  • Scottsdale, Arizona
  • +36 more
Dec 22, 2022

Colorectal Cancer Trial in United States (GCC19CART)

Recruiting
  • Colorectal Cancer
  • San Francisco, California
  • +4 more
Dec 20, 2022

Colorectal Cancer, Fatigue Trial in Boston (UNTIRE App)

Not yet recruiting
  • Colorectal Cancer
  • Fatigue
  • UNTIRE App
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Dec 5, 2022

Colon Cancer, Colorectal Cancer, Rectal Cancer Trial in Worldwide (Panitumumab, Bevacizumab, mFOLFOX6)

Completed
Has Results
  • Colon Cancer
  • +3 more
  • Birmingham, Alabama
  • +94 more
Nov 10, 2022

Concordance Between Colonoscopy Follow up Interval Noted in Patient Letters vs. Electronic Health Record Chart, Colorectal

Recruiting
  • Concordance Between Colonoscopy Follow up Interval Noted in Patient Letters vs. Electronic Health Record Chart
  • Colorectal Cancer
  • Assistance with implementing Epic Smartlist
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 29, 2022

Colorectal Adenoma, Colorectal Cancer, Endoscopic Surgery Trial in Boston (AMR101)

Completed
  • Colorectal Adenoma
  • +4 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 18, 2022

Breast Cancer, Colorectal Cancer, Prostate Cancer Trial in Boston (Supervised Home-Based Exercise, Unsupervised Home-Based

Recruiting
  • Breast Cancer
  • +2 more
  • Supervised Home-Based Exercise
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 14, 2022

Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • PY159 Single agent dose level 1
  • +17 more
  • San Francisco, California
  • +11 more
Nov 3, 2022

Oesophageal Squamous Cell Carcinoma, Gastric Cancer, Hepatocellular Carcinoma Trial in Worldwide (THOR-707, Pembrolizumab,

Active, not recruiting
  • Oesophageal Squamous Cell Carcinoma
  • +4 more
  • Duarte, California
  • +39 more
Oct 31, 2022

Genetic Testing, Breast Cancer, Ovarian Cancer Trial in Boston (Video Education, Genetic Counseling)

Recruiting
  • Genetic Testing
  • +8 more
  • Video Education
  • Genetic Counseling
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Oct 31, 2022

Coronary Artery Disease, Atrial Fibrillation, Type 2 Diabetes Trial in Boston (Polygenic risk score (PRS))

Recruiting
  • Coronary Artery Disease
  • +5 more
  • Polygenic risk score (PRS)
  • Boston, Massachusetts
    VA Boston Healthcare System
Sep 29, 2022

Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal

Recruiting
  • Breast Cancer
  • +15 more
  • ATRC-101
  • +2 more
  • Phoenix, Arizona
  • +10 more
Sep 28, 2022

Colorectal Cancer Trial in Boston (Aspirin, Placebo for Aspirin)

Active, not recruiting
Has Results
  • Colorectal Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Aug 31, 2022

Biomarkers in Subjects With Untreated Solid Tumors

Completed
  • Breast Cancer
  • +12 more
  • Blood Sample Collection
  • Phoenix, Arizona
  • +118 more
Aug 31, 2022